FDA’s New COVID Vax Plan Has Docs Split

Big shakeup in the COVID vaccine world! The FDA’s advisors just voted to update shots for the JN.1 strain, but the real drama? The FDA’s hinting at a new plan: only high-risk folks and seniors might get recommended for future boosters, not everyone. Experts are totally split on which strain to target next, and there’s a lot of side-eye about how this will affect vaccine makers like Novavax and Sanofi. Meanwhile, political pushback is heating up. Stay tuned—this could change how we all get vaxxed! #COVID19 #FDA #Vaccines #Health